Related Experiment Video
Updated: Apr 13, 2026
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Assessing the impact of delivery method on severe maternal morbidity among individuals with inflammatory bowel
Andrea N Simpson1,2,3,4, Rinku Sutradhar2,4, Eric I Benchimol2,4,5,6
1Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON, Canada.
Background & Aims:
Individuals with inflammatory bowel disease (IBD) may have worse obstetrical outcomes than those without IBD. We assessed the odds of severe maternal morbidity (SMM) among individuals with IBD compared to those without by IBD subtype (Crohn's disease [CD] or ulcerative colitis [UC]), and whether the method of delivery impacted the odds of SMM.
Methods:
We conducted a retrospective, population-based matched cohort study of females aged 15-49 years in Ontario, Canada from 2003 to 2019 delivering at 20+ weeks' gestation. The primary outcome was SMM occurring between 20 weeks' gestation up to 42-days postpartum. We identified deliveries among individuals with IBD using health administrative data and matched them 1:5 to deliveries among individuals without IBD from the general population of Ontario residents. Multivariable regression models estimated the adjusted odds ratio (OR) of SMM in antepartum and postpartum periods. We tested for interactions between IBD status and delivery method.
Results:
6833 deliveries in individuals with IBD (3800 CD and 3033 UC) were matched to 34 165 non-IBD deliveries. More individuals with IBD underwent C-section (36.5% vs 30.9%, standardized mean difference, SMD: 0.12). Compared with individuals without IBD, those with IBD had higher odds of antepartum SMM (OR: 3.5, 95% CI: 2.1-5.8) and postpartum SMM (OR: 1.3, 95% CI: 1.0-1.5). The odds of SMM among individuals with and without IBD was not modified by method of delivery (interaction term P = .17).
Conclusions:
Individuals with IBD were at increased risk of SMM, independent of delivery method. Pregnancy care should focus on optimization of other IBD-related risk factors.
Related Concept Videos
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids